We’re excited to announce the formation of the LNP Alliance — a strategic partnership between Phosphorex, NOF CORPORATION, NeoSome Life Sciences, NanoImaging Services, and Envol Biomedical.
This alliance unites world-class expertise in lipid chemistry, formulation development, process optimization, cryo-TEM imaging, and in vivo pharmacology to streamline the development of LNP-based therapeutics from concept to clinic.
A Comprehensive End-to-End LNP Solution
• Proprietary lipid innovations
• Expert formulation & process development
• Cryo-EM nanoparticle characterization
• In vitro analysis and in vivo imaging for biodistribution
• Preclinical Pharmacology & Toxicology (incl. NHP models)
Why Partner with The LNP Alliance?
• Faster development timelines
• Expert-driven solutions to complex challenges
• Seamless support from preclinical to clinical
• Access to exclusive technologies & materials
Learn more or explore partnership opportunities: LNPalliance@phosphorex.com
About the LNP Alliance Partners
Phosphorex – A leading CRO / CDMO specializing in drug delivery, offering expertise in LNP formulation, process development, scale-up and manufacturing. For more info, visit www.phosphorex.com
NOF CORPORATION – A global pioneer in PEG and lipid chemistry, providing high-performance ionizable lipids, PEG lipids, and excipients for advanced drug delivery applications. For more info, visit www.dds-drug.com
NeoSome Life Sciences – An innovative preclinical CRO providing comprehensive in vitro and in vivo services tosupport drug discovery and development across various therapeutic areas. For more info, visit www.neosomels.com
NanoImaging Services – A leader in cryo-electron microscopy (cryo-EM) and nanoparticle characterization, ensuring the highest quality and integrity for LNP-based therapeutics. For more info, visit www.nanoimagingservices.com
Envol Biomedical – A leading non-clinical laboratory offering pharmacology and toxicology capabilities focused on Non-Human Primates. For more info, visit www.envolbio.com
© 2005 - 2025 NOF AMERICA CORPORATION.